Dendritic cell-mediated immune humanization of mice: Implications for allogeneic and xenogeneic stem cell transplantation

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4636-4647

  Salguero, Gustavo ^a   Daenthanasanmak, Anusara ^a   Münz, Christian ^b   Raykova, Ana ^b   Guzmán, Carlos A ^c   Riese, Peggy ^c   Figueiredo, Constanca ^a   Länger, Florian ^a   Schneider, Andreas ^a   Macke, Laura ^a   Sundarasetty, Bala Sai ^a   Witte, Torsten ^a   Ganser, Arnold ^a   Stripecke, Renata ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; XENOGENEIC STEM CELL TRANSPLANTATION;

ADOPTIVE TRANSFER; ALLOGRAFTS; ANIMALS; CYTOMEGALOVIRUS; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROGRAFTS; HUMANS; INTERFERON-ALPHA; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PHOSPHOPROTEINS; TRANSPLANTATION CHIMERA; TUMOR NECROSIS FACTOR-ALPHA; VIRAL MATRIX PROTEINS;

EID: 84901267182     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302887     Document Type: Article

References (44)

1. Gill, S., and D. L. Porter. 2013. Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect. Annu. Rev. Med. 64: 101-117.
2. Filipovich, A. 2008. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Bone Marrow Transplant. 42(Suppl. 1): S49-S52.
3. Oevermann, L., P. Lang, T. Feuchtinger, M. Schumm, H. M. Teltschik, P. Schlegel, and R. Handgretinger. 2012. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation. Ann. N.Y. Acad. Sci. 1266: 161-170.
4. Storb, R., B. Gyurkocza, B. E. Storer, M. L. Sorror, K. Blume, D. Niederwieser, T. R. Chauncey, M. A. Pulsipher, F. B. Petersen, F. Sahebi, et al. 2013. Graftversus- host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 31: 1530-1538.
5. Mielcarek, M., B. Storer, P. J. Martin, S. J. Forman, R. S. Negrin, M. E. Flowers, Y. Inamoto, T. R. Chauncey, R. Storb, F. R. Appelbaum, and W. I. Bensinger. 2012. Long-term outcomes after transplantation of HLA-identical related GCSF-mobilized peripheral blood mononuclear cells versus bone marrow. Blood 119: 2675-2678.
6. Seggewiss, R., and H. Einsele. 2010. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 115: 3861-3868.
7. Marie-Cardine, A., F. Divay, I. Dutot, A. Green, A. Perdrix, O. Boyer, N. Contentin, H. Tilly, F. Tron, J. P. Vannier, and S. Jacquot. 2008. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin. Immunol. 127: 14-25.
8. Roncarolo, M. G., S. Gregori, B. Lucarelli, F. Ciceri, and R. Bacchetta. 2011. Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol. Rev. 241: 145-163.
9. Mori, T., and J. Kato. 2010. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int. J. Hematol. 91: 588-595.
10. Steinman, R. M. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30: 1-22.
11. Wendland, M., S. Willenzon, J. Kocks, A. C. Davalos-Misslitz, S. I. Hammerschmidt, K. Schumann, E. Kremmer, M. Sixt, A. Hoffmeyer, O. Pabst, and R. Fölrster. 2011. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35: 945-957.
12. Verdijk, P., E. H. Aarntzen, W. J. Lesterhuis, A. C. Boullart, E. Kok, M. M. van Rossum, S. Strijk, F. Eijckeler, J. J. Bonenkamp, J. F. Jacobs, et al. 2009. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 15: 2531-2540.
13. Daenthanasanmak, A., G. Salguero, S. Borchers, C. Figueiredo, R. Jacobs, B. S. Sundarasetty, A. Schneider, A. Schambach, B. Eiz-Vesper, R. Blasczyk, et al. 2012. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. Vaccine 30: 5118-5131.
14. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123-6132.
15. Salguero, G., B. S. Sundarasetty, S. Borchers, D. Wedekind, B. Eiz-Vesper, S. Velaga, A. C. Jirmo, G. Behrens, G. Warnecke, A. K. Knöl fel, et al. 2011. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rgc-/- mice. Hum. Gene Ther. 22: 1209-1224.
16. Stripecke, R. 2009. Lentiviral vector-mediated genetic programming of mouse and human dendritic cells. Methods Mol. Biol. 506: 139-158.
17. Harrell, M. I., B. M. Iritani, and A. Ruddell. 2008. Lymph node mapping in the mouse. J. Immunol. Methods 332: 170-174.
18. Maetzig, T., M. Galla, M. H. Brugman, R. Loew, C. Baum, and A. Schambach. 2010. Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Ther. 17: 400-411.
19. Rothe, M., I. Rittelmeyer, M. Iken, U. Rudrich, A. Schambach, S. Glage, M. P. Manns, C. Baum, M. Bock, M. Ott, and U. Modlich. 2012. Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes. Gene Ther. 19: 425-434.
20. Lerner, K. G., G. F. Kao, R. Storb, C. D. Buckner, R. A. Clift, and E. D. Thomas. 1974. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant. Proc. 6: 367-371.
21. Becker, P. D., N. Legrand, C. M. van Geelen, M. Noerder, N. D. Huntington, A. Lim, E. Yasuda, S. A. Diehl, F. A. Scheeren, M. Ott, et al. 2010. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS One 5:5.
22. Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2: 223-238.
23. Koya, R. C., T. Kimura, A. Ribas, N. Rozengurt, G.W. Lawson, E. Faure-Kumar, H. J. Wang, H. Herschman, N. Kasahara, and R. Stripecke. 2007. Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines. Mol. Ther. 15: 971-980.
24. Pincha, M., G. Salguero, D. Wedekind, B. S. Sundarasetty, A. Lin, N. Kasahara, M. H. Brugman, A. C. Jirmo, U. Modlich, R. Gutzmer, et al. 2011. Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells. Gene Ther. 18: 750-764.
25. Sundarasetty, B. S., V. K. Singh, G. Salguero, R. Geffers, M. Rickmann, L. Macke, S. Borchers, C. Figueiredo, A. Schambach, U. Gullberg, et al. 2013. Lentivirus-induced dendritic cells for immunization against high-risk WT1+ acute myeloid leukemia. Hum. Gene Ther. 24: 220-237.
26. Lapenta, C., S. M. Santini, M. Spada, S. Donati, F. Urbani, D. Accapezzato, D. Franceschini, M. Andreotti, V. Barnaba, and F. Belardelli. 2006. IFNa-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens. Eur. J. Immunol. 36: 2046-2060.
27. Cobb, A., L. K. Roberts, A. K. Palucka, H. Mead, M. Montes, R. Ranganathan, S. Burkeholder, J. P. Finholt, D. Blankenship, B. King, et al. 2011. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine. J. Immunol. Methods 365: 27-37.
28. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor g chain(null) mice. Blood 106: 1565-1573.
29. Shultz, L. D., M. A. Brehm, J. V. Garcia-Martinez, and D. L. Greiner. 2012. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 12: 786-798.
30. Lepus, C. M., T. F. Gibson, S. A. Gerber, I. Kawikova, M. Szczepanik, J. Hossain, V. Ablamunits, N. Kirkiles-Smith, K. C. Herold, R. O. Donis, et al. 2009. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gc-/-, Balb/c-Rag1-/-gc-/-, and C.B-17-scid/bg immunodeficient mice. Hum. Immunol. 70: 790-802.
31. André, M. C., A. Erbacher, C. Gille, V. Schmauke, B. Goecke, A. Hohberger, P. Mang, A. Wilhelm, I. Mueller, W. Herr, et al. 2010. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gnull mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells. J. Immunol. 185: 2710-2720.
32. O'Connell, R. M., A. B. Balazs, D. S. Rao, C. Kivork, L. Yang, and D. Baltimore. 2010. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One 5: e12009.
33. Chen, Q., M. Khoury, and J. Chen. 2009. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc. Natl. Acad. Sci. USA 106: 21783-21788.
34. Hu, Z., and Y. G. Yang. 2012. Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34+ cells. Cell. Mol. Immunol. 9: 232-236.
35. Biswas, S., H. Chang, P. T. N. Sarkis, E. Fikrig, Q. Zhu, and W. A. Marasco. 2011. Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells. Immunology 134: 419-433.
36. Shultz, L. D., Y. Saito, Y. Najima, S. Tanaka, T. Ochi, M. Tomizawa, T. Doi, A. Sone, N. Suzuki, H. Fujiwara, et al. 2010. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/ SCID/IL2r gnull humanized mice. Proc. Natl. Acad. Sci. USA 107: 13022-13027.
37. Danner, R., S. N. Chaudhari, J. Rosenberger, J. Surls, T. L. Richie, T. D. Brumeanu, and S. Casares. 2011. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 6: e19826.
38. Willinger, T., A. Rongvaux, H. Takizawa, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, W. Auerbach, E. E. Eynon, S. Stevens, M. G. Manz, and R. A. Flavell. 2011. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. USA 108: 2390-2395.
39. Singh, M., P. Singh, G. Gaudray, L. Musumeci, C. Thielen, D. Vaira, C. Vandergeeten, L. Delacroix, E. Van Gulck, G. Vanham, et al. 2012. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2RgNULL mice allows HIV replication and development of anti-HIV Immune Responses. PLoS One 7: e38491.
40. Marodon, G., D. Desjardins, L. Mercey, C. Baillou, P. Parent, M. Manuel, C. Caux, B. Bellier, N. Pasqual, and D. Klatzmann. 2009. High diversity of the immune repertoire in humanized NOD.SCID.gc-/- mice. Eur. J. Immunol. 39: 2136-2145.
41. Sun, Z., P. W. Denton, J. D. Estes, F. A. Othieno, B. L. Wei, A. K. Wege, M. W. Melkus, A. Padgett-Thomas, M. Zupancic, A. T. Haase, and J. V. Garcia. 2007. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 204: 705-714.
42. Lang, J., M. Kelly, B. M. Freed, M. D. McCarter, R. M. Kedl, R. M. Torres, and R. Pelanda. 2013. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J. Immunol. 190: 2090-2101.
43. Tanaka, S., Y. Saito, J. Kunisawa, Y. Kurashima, T. Wake, N. Suzuki, L. D. Shultz, H. Kiyono, and F. Ishikawa. 2012. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/ SCID/IL2rgKO mice. J. Immunol. 188: 6145-6155.
44. Pincha, M., B. S. Sundarasetty, G. Salguero, R. Gutzmer, H. Garritsen, L. Macke, A. Schneider, D. Lenz, C. Figueiredo, R. Blasczyk, et al. 2012. Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. Hum. Gene Ther. Methods 23: 38-55.